Constraint-induced or multi-modal personalized aphasia rehabilitation (COMPARE): A randomized controlled trial for stroke-related chronic aphasia

Abstract

Rationale

The comparative efficacy and cost-effectiveness of constraint-induced and multi-modality aphasia therapy in chronic stroke are unknown.

Aims and hypotheses

In the COMPARE trial, we aim to determine whether Multi-Modal Aphasia Treatment (M-MAT) and Constraint-Induced Aphasia Therapy Plus (CIAT-Plus) are superior to usual care (UC) for chronic post-stroke aphasia. Primary hypothesis: CIAT-Plus and M-MAT will reduce aphasia severity (Western Aphasia Battery-Revised Aphasia Quotient (WAB-R-AQ)) compared with UC: CIAT-Plus superior for moderate aphasia; M-MAT superior for mild and severe aphasia.

Sample size estimates

A total of 216 participants (72 per arm) will provide 90% power to detect a 5-point difference on the WAB-R-AQ between CIAT-Plus or M-MAT and UC at α = 0.05.

Methods and design

Prospective, randomized, parallel group, open-label, assessor blinded trial. Participants: Stroke >6 months; aphasia severity categorized using WAB-R-AQ. Computer-generated blocked and stratified randomization by aphasia severity (mild, moderate, and severe), to 3 arms: CIAT-Plus, M-MAT (both 30 h therapy over two weeks); UC (self-reported usual community care).

Study outcomes

WAB-R-AQ immediately post-intervention. Secondary outcomes: WAB-R-AQ at 12-week follow-up; naming scores, discourse measures, Communicative Effectiveness Index, Scenario Test, and Stroke and Aphasia Quality of Life Scale-39 g immediately and at 12 weeks post-intervention; incremental cost-effectiveness ratios compared with UC at 12 weeks.

Discussion

This trial will determine whether CIAT-Plus and M-MAT are superior and more cost-effective than UC in chronic aphasia. Participant subgroups with the greatest response to CIAT-Plus and M-MAT will be described.

Keywords

Aphasia therapy stroke multimodal constraint intensity rehabilitation randomized controlled trial

Get full access to this article

View all access options for this article.

References

Flowers

Skoretz

Silver

, et al. Poststroke aphasia frequency, recovery and outcomes: a systematic review and meta-analysis. Arch Phys Med Rehabil 2016; 97: 2188–2201.e8.

Kauhanen

Korpelainen

Hiltunen

, et al. Aphasia, depression, and non-verbal cognitive impairment in ischaemic stroke. Cerebrovasc Dis 2000; 10: 455–461.

Hilari

Byng

. Health-related quality of life in people with severe aphasia. Int J Lang Commun Disord 2009; 44: 193–205.

Brady

Kelly

Godwin

Enderby

Campbell

. Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev 2016; 6: CD000425.

Breitenstein

Grewe

Floel

, et al. Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomized, open-label, blinded-endpoint, controlled trial in a health-care setting. Lancet 2017; 389: 1528–1538.

Meinzer

Rodriguez

Gonzalez Rothi

. First decade of research on constrained-induced treatment approaches for aphasia rehabilitation. Arch Phys Med Rehabil 2012; 93: S35–S45.

Rose

Attard

Mok

Lanyon

Foster

. Multi-modality aphasia therapy is as efficacious as constraint induced aphasia therapy: a phase one study. Aphasiology 2013; 27: 938–971.

Zhang

Bao

. Constraint-induced aphasia therapy in post-stroke aphasia rehabilitation. A systematic review and meta-analysis of randomized controlled trials. PLOS One 2017; 12: e0183349.

Kertesz

. The Western aphasia battery-revised, New York: Grune & Stratton, 2007.

10.

Boutron

Altman

Moher

, et al. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med 2017; 67: 40.

11.

Harris

Taylor

Thielke

Payne

Gonzalez

Conde

. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377–381.

12.

Wallace

Worrall

Rose

. A core outcome set for aphasia treatment research: the ROMA consensus statement. Int J Stroke 2019; 14: 180–185.

13.

Hilari

Byng

Lamping

Smith

. Stroke and aphasia quality of life scale-39 (SAQOL-39): evaluation of acceptability, reliability, and validity. Stroke 2013; 34: 1944–1950.

14.

Viney

Norman

Brazier

, et al. An Australian discrete choice experiment to value EQ-5D health states. Health Econ 2014; 23: 729–742.

15.

van der Meulen

van de Sandt-Koenderman

WME

Duivenvoorden

Ribbers

. Measuring verbal and non-verbal communication in aphasia: reliability, validity, and sensitivity to change of the scenario test. Int J Lang Com Dis 2010; 45: 424–435.

16.

Lomas

Prickard

Bester

, et al. The communicative effectiveness index: development and psychometric evaluation of a functional communication measure for adult aphasia. J Speech Hear Dis 1989; 54: 113–124.